<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39469273</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2312-0541</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>ERJ open research</Title><ISOAbbreviation>ERJ Open Res</ISOAbbreviation></Journal><ArticleTitle>Persistent disabilities 28 months after COVID-19 hospitalisation, a prospective cohort study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">00104-2024</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/23120541.00104-2024</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Limited data are available on long-term respiratory disabilities in patients following acute COVID-19.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">This prospective, monocentric, observational cohort study included patients admitted to our hospital with acute COVID-19 between 12 March and 24 April 2020. Clinical, functional and radiological data were collected up to 28 months after hospital discharge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 715 patients hospitalised for COVID-19, 493 (69.0%) were discharged alive. We could access complete medical records for 268 out of 493 patients (54.4%); 138 out of 268 (51.5%) exhibited persistent respiratory symptoms and agreed with the data collection and follow-up. Patients were predominantly male (64.5%), with a mean±sd age of 58.9±15.3 years. At the last follow-up, the leading symptoms were asthenia (31.5%), dyspnoea (29.8%) and neuropsychological symptoms (17.7%). Lung function improved up to the last visit. Mean diffusing capacity of the lung for carbon monoxide (<i>D</i> <sub>LCO</sub>) was 77.8% of predicted value, total lung capacity (TLC) was 83.5% and O<sub>2</sub> desaturation during exercise (O<sub>2</sub> desaturation) was 2.3%. While <i>D</i> <sub>LCO</sub> improved over the entire period, TLC improved in the early phase and O<sub>2</sub> desaturation in the late phase. Except for those with lung comorbidities, only one patient presented with minor functional and chest radiological alterations at 28 months.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Patients with acute COVID-19 discharged alive showed improved clinical symptoms, lung function parameters and radiological signs up to 28 months post-infection. Persistent symptoms consisted mainly of asthenia and dyspnoea, with lung function returning to normal. One patient without prior respiratory issues exhibited moderate pulmonary fibrosis.</AbstractText><CopyrightInformation>Copyright ©The authors 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Renaud</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Unité d'Explorations Fonctionnelles Respiratoires et du Sommeil, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculté de Médecine, Université Paris Cité, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Both authors contributed equally to this study.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chocron</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5498-8937</Identifier><AffiliationInfo><Affiliation>Service d'urgence, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paris Cardiovascular Research Center, INSERM 970, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Both authors contributed equally to this study.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reverdito</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Paris Cardiovascular Research Center, INSERM 970, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanchard</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre d'Investigation Clinique 1418, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hua-Huy</LastName><ForeName>Thong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Unité d'Explorations Fonctionnelles Respiratoires et du Sommeil, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diehl</LastName><ForeName>Jean-Luc</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0001-5378-6762</Identifier><AffiliationInfo><Affiliation>Faculté de Médecine, Université Paris Cité, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Medicine Department, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livrozet</LastName><ForeName>Marine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre d'Investigation Clinique 1418, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subileau</LastName><ForeName>Marielle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unité d'Explorations Fonctionnelles Respiratoires et du Sommeil, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemogne</LastName><ForeName>Cédric</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service de Psychiatrie de l'Adulte, Hôpital Hôtel-Dieu, AP-HP, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Université Paris Cité and Université Sorbonne Paris Nord, INSERM, INRAE, Centre for Research in Epidemiology and StatisticS (CRESS).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Batti</LastName><ForeName>Salma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculté de Médecine, Université Paris Cité, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Chirurgie Vasculaire, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Auclin</LastName><ForeName>Edouard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Paris Cardiovascular Research Center, INSERM 970, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service d'Oncologie Médicale, Institut du Cancer Paris CARPEM, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jannot</LastName><ForeName>Anne-Sophie</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Centre de Recherche des Cordeliers, HeKA INSERM UMRS 1138, INRIA Paris, Université Paris Cité, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Départment de Bioinformatique Médicale, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Banque Nationale de Données Maladies Rares, Direction des Services Numériques, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rance</LastName><ForeName>Bastien</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre de Recherche des Cordeliers, HeKA INSERM UMRS 1138, INRIA Paris, Université Paris Cité, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Départment de Bioinformatique Médicale, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mousseaux</LastName><ForeName>Elie</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8076-1445</Identifier><AffiliationInfo><Affiliation>Paris Cardiovascular Research Center, INSERM 970, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smadja</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Service d'Hématologie et Laboratoire de Recherches Biochirurgicales, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Innovative Therapies in Haemostasis, INSERM UMR S1140, Université Paris Cité, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebeaux</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculté de Médecine, Université Paris Cité, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Microbiologie, Unité Mobile d'Infectiologie, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulot</LastName><ForeName>Jean-Sébastien</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Paris Cardiovascular Research Center, INSERM 970, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre d'Investigation Clinique 1418, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Innovative Therapies in Haemostasis, INSERM UMR S1140, Université Paris Cité, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Pneumologie et soins Intensifs, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Günther</LastName><ForeName>Sven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8388-6131</Identifier><AffiliationInfo><Affiliation>Unité d'Explorations Fonctionnelles Respiratoires et du Sommeil, Hôpital Européen Georges-Pompidou, AP-HP, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Innovative Therapies in Haemostasis, INSERM UMR S1140, Université Paris Cité, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ERJ Open Res</MedlineTA><NlmUniqueID>101671641</NlmUniqueID><ISSNLinking>2312-0541</ISSNLinking></MedlineJournalInfo><CoiStatement>Conflict of interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>4</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39469273</ArticleId><ArticleId IdType="pmc">PMC11514200</ArticleId><ArticleId IdType="doi">10.1183/23120541.00104-2024</ArticleId><ArticleId IdType="pii">00104-2024</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization (WHO) . Coronavirus (COVID-19) Dashboard. Date last updated: 20 December 2023. Date last accessed: 21 December 2023. https://covid19.who.int/table</Citation></Reference><Reference><Citation>Hu B, Guo H, Zhou P, et al. . Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021; 19: 141–154. doi:10.1038/s41579-020-00459-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Zangrillo A, Zanella A, et al. . Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA 2020; 323: 1574–1581. doi:10.1001/jama.2020.5394</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5394</ArticleId><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators , Wulf Hanson S, Abbafati C, et al. . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 2022; 328: 1604–1615. doi:10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X, Jian W, Su Z, et al. . Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J 2020; 55: 2001217. doi:10.1183/13993003.01217-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Tan C, Wu J, et al. . Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res 2020; 21: 163. doi:10.1186/s12931-020-01429-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01429-6</ArticleId><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Frija-Masson J, Debray MP, Gilbert M, et al. . Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur Respir J 2020; 56: 2001754. doi:10.1183/13993003.01754-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01754-2020</ArticleId><ArticleId IdType="pmc">PMC7301832</ArticleId><ArticleId IdType="pubmed">32554533</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, et al. . Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine 2020; 25: 100463. doi:10.1016/j.eclinm.2020.100463</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Smet J, Stylemans D, Hanon S, et al. . Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection. Respir Med 2021; 176: 106276. doi:10.1016/j.rmed.2020.106276</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106276</ArticleId><ArticleId IdType="pmc">PMC7701883</ArticleId><ArticleId IdType="pubmed">33278758</ArticleId></ArticleIdList></Reference><Reference><Citation>Darcis G, Bouquegneau A, Maes N, et al. . Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. Int J Infect Dis 2021; 109: 209–216. doi:10.1016/j.ijid.2021.07.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.07.016</ArticleId><ArticleId IdType="pmc">PMC8278829</ArticleId><ArticleId IdType="pubmed">34273510</ArticleId></ArticleIdList></Reference><Reference><Citation>Stylemans D, Smet J, Hanon S, et al. . Evolution of lung function and chest CT 6 months after COVID-19 pneumonia: real-life data from a Belgian University Hospital. Respir Med 2021; 182: 106421. doi:10.1016/j.rmed.2021.106421</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106421</ArticleId><ArticleId IdType="pmc">PMC8053365</ArticleId><ArticleId IdType="pubmed">33901788</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlemmer F, Valentin S, Boyer L, et al. . Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study. Eur Respir J 2023; 61: 2201532. doi:10.1183/13993003.01532-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01532-2022</ArticleId><ArticleId IdType="pmc">PMC10066566</ArticleId><ArticleId IdType="pubmed">36669777</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrivankova VW, Richmond RC, Woolf BAR, et al. . Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 2021; 326: 1614–1621. doi:10.1001/jama.2021.18236</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.18236</ArticleId><ArticleId IdType="pubmed">34698778</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojevic S, Graham BL, Cooper BG, et al. . Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians. Eur Respir J 2017; 50: 1700010. doi:10.1183/13993003.00010-2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00010-2017</ArticleId><ArticleId IdType="pubmed">28893868</ArticleId></ArticleIdList></Reference><Reference><Citation>Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998; 158: 1384–1387. doi:10.1164/ajrccm.158.5.9710086</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.158.5.9710086</ArticleId><ArticleId IdType="pubmed">9817683</ArticleId></ArticleIdList></Reference><Reference><Citation>Charpentier E, Soulat G, Fayol A, et al. . Visual lung damage CT score at hospital admission of COVID-19 patients and 30-day mortality. Eur Radiol 2021; 31: 8354–8363. doi:10.1007/s00330-021-07938-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-021-07938-2</ArticleId><ArticleId IdType="pmc">PMC8083100</ArticleId><ArticleId IdType="pubmed">33914118</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, et al. . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383. doi:10.1016/0021-9681(87)90171-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight SR, Ho A, Pius R, et al. . Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: development and validation of the 4C mortality score. BMJ 2020; 370: m3339. doi:10.1136/bmj.m3339</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3339</ArticleId><ArticleId IdType="pmc">PMC7116472</ArticleId><ArticleId IdType="pubmed">32907855</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel KS, Geisler R, Maier D, et al. . A systematic review of predictor composition, outcomes, risk of bias, and validation of COVID-19 prognostic scores. Clin Infect Dis 2024; 78: 889–899. doi:10.1093/cid/ciad618</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad618</ArticleId><ArticleId IdType="pmc">PMC11006104</ArticleId><ArticleId IdType="pubmed">37879096</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, progesterone, immunomodulation, and COVID-19 outcomes. Endocrinology 2020; 161: bqaa127. doi:10.1210/endocr/bqaa127</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqaa127</ArticleId><ArticleId IdType="pmc">PMC7438701</ArticleId><ArticleId IdType="pubmed">32730568</ArticleId></ArticleIdList></Reference><Reference><Citation>Izcovich A, Ragusa MA, Tortosa F, et al. . Prognostic factors for severity and mortality in patients infected with COVID-19: a systematic review. PLoS One 2020; 15: e0241955. doi:10.1371/journal.pone.0241955</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241955</ArticleId><ArticleId IdType="pmc">PMC7671522</ArticleId><ArticleId IdType="pubmed">33201896</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T, Ellingson MK, Wong P, et al. . Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 2020; 588: 315–320. doi:10.1038/s41586-020-2700-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienvenu LA, Noonan J, Wang X, et al. . Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res 2020; 116: 2197–2206. doi:10.1093/cvr/cvaa284</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa284</ArticleId><ArticleId IdType="pmc">PMC7665363</ArticleId><ArticleId IdType="pubmed">33063089</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges do Nascimento IJ, O'Mathuna DP, von Groote TC, et al. . Coronavirus disease (COVID-19) pandemic: an overview of systematic reviews. BMC Infect Dis 2021; 21: 525. doi:10.1186/s12879-021-06214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06214-4</ArticleId><ArticleId IdType="pmc">PMC8177249</ArticleId><ArticleId IdType="pubmed">34088271</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu L, Tebe C, Loste C, et al. . Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study. Lancet Reg Health Eur 2023; 33: 100724. doi:10.1016/j.lanepe.2023.100724</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100724</ArticleId><ArticleId IdType="pmc">PMC10636281</ArticleId><ArticleId IdType="pubmed">37954002</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38: 101019. doi:10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivaldi G, Pfeffer PE, Talaei M, et al. . Long-term symptom profiles after COVID-19 vs other acute respiratory infections: an analysis of data from the COVIDENCE UK study. EClinicalMedicine 2023; 65: 102251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10721552</ArticleId><ArticleId IdType="pubmed">38106559</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway EM, Mackman N, Warren RQ, et al. . Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 2022; 22: 639–649. doi:10.1038/s41577-022-00762-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00762-9</ArticleId><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–1062. doi:10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng B, Daines L, Han Q, et al. . Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis. Eur Respir Rev 2022; 31: 220071. doi:10.1183/16000617.0071-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0071-2022</ArticleId><ArticleId IdType="pmc">PMC9724798</ArticleId><ArticleId IdType="pubmed">36323418</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Cancela-Cilleruelo I, Rodriguez-Jimenez J, et al. . Trajectory of post-COVID self-reported fatigue and dyspnoea in individuals who had been hospitalized by COVID-19: the LONG-COVID-EXP multicenter study. Biomedicines 2023; 11: 1863. doi:10.3390/biomedicines11071863</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11071863</ArticleId><ArticleId IdType="pmc">PMC10376654</ArticleId><ArticleId IdType="pubmed">37509504</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Mahoney LL, Routen A, Gillies C, et al. . The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine 2023; 55: 101762. doi:10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, et al. . Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open 2021; 4: e2036142. doi:10.1001/jamanetworkopen.2020.36142</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Shi L, Wang Y, et al. . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8: 420–422. doi:10.1016/S2213-2600(20)30076-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A, Balfanz P, Cornelissen C, et al. . Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Respir Med 2020; 174: 106197. doi:10.1016/j.rmed.2020.106197</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106197</ArticleId><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbeis F, Thibeault C, Doellinger F, et al. . Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: an observational longitudinal study over 12 months. Respir Med 2022; 191: 106709. doi:10.1016/j.rmed.2021.106709</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106709</ArticleId><ArticleId IdType="pmc">PMC8632363</ArticleId><ArticleId IdType="pubmed">34871947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, et al. . 3-month, 6–month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med 2021; 9: 747–754. doi:10.1016/S2213-2600(21)00174-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusart C, Smet J, Chirumberro A, et al. . Pulmonary functional outcomes at 3 months in critical COVID-19 survivors hospitalized during the first, second, and third pandemic waves. J Clin Med 2023; 12: 3712. doi:10.3390/jcm12113712</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12113712</ArticleId><ArticleId IdType="pmc">PMC10253272</ArticleId><ArticleId IdType="pubmed">37297906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino P, Maniscalco M. Deconditioning in COVID-19 survivors with reduced exercise performance: a role for endothelial dysfunction? Med Hypotheses 2022; 163: 110847. doi:10.1016/j.mehy.2022.110847</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2022.110847</ArticleId><ArticleId IdType="pmc">PMC9012505</ArticleId><ArticleId IdType="pubmed">35464997</ArticleId></ArticleIdList></Reference><Reference><Citation>Edward JA, Peruri A, Rudofker E, et al. . Characteristics and treatment of exercise intolerance in patients with long COVID. J Cardiopulm Rehabil Prev 2023; 43: 400–406. doi:10.1097/HCR.0000000000000821</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCR.0000000000000821</ArticleId><ArticleId IdType="pubmed">37646620</ArticleId></ArticleIdList></Reference><Reference><Citation>Odriozola-Gonzalez P, Planchuelo-Gomez A, Irurtia MJ, et al. . Psychological effects of the COVID-19 outbreak and lockdown among students and workers of a Spanish university. Psychiatry Res 2020; 290: 113108. doi:10.1016/j.psychres.2020.113108</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113108</ArticleId><ArticleId IdType="pmc">PMC7236679</ArticleId><ArticleId IdType="pubmed">32450409</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng B, Vivaldi G, Daines L, et al. . Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls. Lancet Reg Health Eur 2023; 29: 100635. doi:10.1016/j.lanepe.2023.100635</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100635</ArticleId><ArticleId IdType="pmc">PMC10145209</ArticleId><ArticleId IdType="pubmed">37261214</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottemanne H, Gouraud C, Hulot JS, et al. . Do anxiety and depression predict persistent physical symptoms after a severe COVID-19 episode? A prospective study. Front Psychiatry 2021; 12: 757685. doi:10.3389/fpsyt.2021.757685</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.757685</ArticleId><ArticleId IdType="pmc">PMC8631493</ArticleId><ArticleId IdType="pubmed">34858230</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurnier A, Savale L, Jais X, et al. . Functional respiratory complaints among COVID-19 survivors: a prospective cohort study. ERJ Open Res 2023; 9: 00063-2023. doi:10.1183/23120541.00063-2023</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00063-2023</ArticleId><ArticleId IdType="pmc">PMC9969230</ArticleId><ArticleId IdType="pubmed">37131523</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison OK, Hayen A, Wager TD, et al. . Investigating the specificity of the neurologic pain signature against breathlessness and finger opposition. Pain 2021; 162: 2933–2944. doi:10.1097/j.pain.0000000000002327</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002327</ArticleId><ArticleId IdType="pmc">PMC8600542</ArticleId><ArticleId IdType="pubmed">33990110</ArticleId></ArticleIdList></Reference><Reference><Citation>Righini M, Van Es J, Den Exter PL, et al. . Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA 2014; 311: 1117–1124. doi:10.1001/jama.2014.2135</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.2135</ArticleId><ArticleId IdType="pubmed">24643601</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>